PHARMACOKINETICS AND IMMUNOGENICITY ASSESSMENT OF A SINGLE SUBCUTANEOUS DOSE OF CASIRIVIMAB AND IMDEVIMAB IN HOUSEHOLD CONTACTS OF SARS-COV-2 INFECTED PERSONS
Clinical Pharmacology & Therapeutics
; 111:S23-S24, 2022.
Article
in English
| Web of Science | ID: covidwho-1695961
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Language:
English
Journal:
Clinical Pharmacology & Therapeutics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS